Newswise — Krutika Kuppalli, MD, an infectious diseases physician who specializes in HIV, has joined Loyola University Health System.

Dr. Kuppalli is board certified in internal medicine and infectious diseases.

She was born in Richmond, Va. and raised in Palo Alto, Calif. She earned her medical degree from Virginia Commonwealth University School of Medicine in Richmond. She also holds a Bachelor of Arts in international relations and political science and a Bachelor of Science in biochemistry and cell biology from the University of California, San Diego.

Dr. Kuppalli completed her internal medicine residency as well as clinical and research fellowships in infectious diseases at Emory University School of Medicine in Atlanta, Ga. She also completed a post-doctoral fellowship in global public health at the University of California, San Diego.

Dr. Kuppalli has 10 years of experience working with persons living with HIV/AIDS. Her research interests include understanding the epidemiology and transmission dynamics of HIV, improving prevention services and understanding social and contextual factors that are barriers to care among HIV-infected individuals. She was a Fogarty Fellow and conducted research in Southern India to further understand barriers to care in women infected with HIV/AIDS. Her other area of interest is the clinical manifestations and pathophysiology of leptospirosis in HIV-infected individuals.

She most recently was working with Partners in Health as part of the organization’s Ebola response in West Africa. While in Sierra Leone she was medical lead for an Ebola Treatment Unit at a district hospital and helped care for critically ill patients with Ebola, ensured appropriate infection-control measures were in place, and assisted with strengthening hospital protocols.

She serves as a manuscript reviewer for PLOS Neglected Tropical Diseases, Malaysian Journal of Medical Sciences and Indian Journal of Critical Care Medicine.

Dr. Kuppalli is an assistant clinical professor in the Division of Infectious Diseases and the lead for antibiotic stewardship at Loyola University Medical Center.

Loyola University Health System is recognized internationally as a leader in infection control and prevention. Loyola is one of a few select hospitals that invest in universal screening of all inpatients for MRSA. Loyola was one of the first institutions to require all staff to have mandatory flu shots as a condition of employment. Loyola was the only academic hospital to participate in a national C. difficile study and performs the most accurate testing for bacteria. Loyola also actively screens Emergency Department patients for HIV/AIDS as part of an ongoing research study.